New study headed by scientists at The University of Texas MD Anderson Cancer Centre offers a better knowledge of the evolution of the tumour microenvironment.
A study by a multidisciplinary team at Weill Cornell Medicine has identified a new protein variant that underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs.
